| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/05/1992 | EP0496852A1 Novel adenosine derivatives, their production and use |
| 08/05/1992 | EP0496753A1 2-bicyclo-benzimidazoles, process for their production and drugs containing said compounds |
| 08/05/1992 | EP0496746A1 Pharmaceutically active amino-substituted heteroaryl amines |
| 08/05/1992 | EP0490944A4 Transmucosal dosage form |
| 08/05/1992 | EP0349609B1 Aminoacid esters, process for their manufacture and their use |
| 08/05/1992 | EP0348431B1 Liposome-incorporated nystatin |
| 08/05/1992 | EP0261185B1 7-oxoprostacycline derivatives and process for their manufacture |
| 08/05/1992 | CN1063287A Process for preparation of 3'-fluoropyrimidine nucleosides |
| 08/05/1992 | CN1063286A Antibacterial agents |
| 08/05/1992 | CN1063284A Antibacterial agents |
| 08/05/1992 | CN1017708B Method for preparation of pyrazolotriazine compounds |
| 08/05/1992 | CN1017707B Process for preparation of new thiazole compounds |
| 08/05/1992 | CN1017706B Process for preparation of 1,5-benzothiazepine derivatives |
| 08/04/1992 | US5136099 Golfomycin derivatives: fused ring cyclodecadiyne derivatives having dna-cleaving properties and antitumor activity |
| 08/04/1992 | US5136090 Biphenyl-5,5'-bis-alkanoic acid derivatives, their production and aldose reductase inhibitors containing the same |
| 08/04/1992 | US5136080 Intermediates for glutamate inhibitors |
| 08/04/1992 | US5136060 Method for preparation of taxol using an oxazinone |
| 08/04/1992 | US5136037 3-(4-substituted-4-piperazinyl)butyl-4-thiazolidinone and related compounds |
| 08/04/1992 | US5135957 Tea polyphenols; applying catechin compounds; fungicides |
| 08/04/1992 | US5135956 Fatty alcohol |
| 08/04/1992 | US5135954 Preventing or decreasing extravasation |
| 08/04/1992 | US5135953 Oral or injections; cattle, swine, poultry |
| 08/04/1992 | US5135952 Antiinflammatory and/or antiallergic methods |
| 08/04/1992 | US5135950 Crystallized from lower aliphatic carboxylic acid with hydrochloric or hydrobromic acid catalyst |
| 08/04/1992 | US5135949 Pharmaceutical compositions containing phenylamides |
| 08/04/1992 | US5135948 Mixture or ascorbic acid and 5,6-benzylideneascorbic acid |
| 08/04/1992 | US5135946 Use of 2,4 monofurfurylidene-sorbitol and its tetraalkyl derivatives in cosmetics and dermatology |
| 08/04/1992 | US5135945 Cholesterol-lowering tocopherol analogs |
| 08/04/1992 | US5135940 Antiallegens, antiinflammatory agents |
| 08/04/1992 | US5135939 Treating thermobotic and vasospastic disease |
| 08/04/1992 | US5135938 Leukotriene antagonists |
| 08/04/1992 | US5135937 Aromatase inhibitors |
| 08/04/1992 | US5135935 Anticholesterol agents |
| 08/04/1992 | US5135934 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents |
| 08/04/1992 | US5135933 Method for transplantation of fertilized ova |
| 08/04/1992 | US5135932 2-hydroxypropylamino-alkyl-benzimidazoly-5-yl derivatives and their use in the treatment of heart disease |
| 08/04/1992 | US5135931 Antidepressants, psychological disorders, nervous system disorders |
| 08/04/1992 | US5135930 Hydrogenated nitrogen containing tetracycles having two nonadjacent lactam rings |
| 08/04/1992 | US5135928 Triazolo derivatives and process for their preparation |
| 08/04/1992 | US5135925 Use of zinc acexamate in the prophylaxis of gastropathy induced by non-steroidal anti-inflammatory drugs |
| 08/04/1992 | US5135924 Therapeutic treatment of animals with oral administration of ormetoprim-potentiated sulfonamides |
| 08/04/1992 | US5135923 Inositol triphosphate |
| 08/04/1992 | US5135922 Prevention and treatment of microbial infection by phosphoglycerides |
| 08/04/1992 | US5135921 Pharmaceutical compositions comprising phosphatidyl carnitine for the treatment of human pathologies associated with neuronal damage |
| 08/04/1992 | US5135920 Angiostatic agents |
| 08/04/1992 | US5135919 Method and a pharmaceutical composition for the inhibition of angiogenesis |
| 08/04/1992 | US5135918 Method for decreasing reaginic antibody levels |
| 08/04/1992 | US5135913 Increasing subcutaneous fat by administering copper-peptide complex |
| 08/04/1992 | US5135753 Method and therapeutic system for smoking cessation |
| 08/04/1992 | US5135751 Composition for reducing postsurgical adhesions |
| 08/04/1992 | US5135746 Control of protozoal disease |
| 08/04/1992 | CA1305972C STABLE SOLVENT ADDUCTS OF Z-1-(P-.beta.- DIMETHYLAMINOETHOXY-PHENYL)-1-(P-HYDROXYPHENYL)-2- PHENYL-BUT-1-ENE |
| 08/04/1992 | CA1305970C Process for producing ifosfamide having improved properties |
| 08/04/1992 | CA1305964C2 1-carba (dethia) cephalosporin 3-triflate ester antibiotics |
| 08/03/1992 | WO1992013863A1 Use of thiazolo-[2,3-a]isoindole derivatives as antiviral medicaments and novel thiazolo-[2,3-a]isoindole derivatives |
| 08/03/1992 | CA2100366A1 Use of thiazolo-[2,3-a]-isoindole derivatives as antiviral medicaments and new thiazolo-[2,3-a]-isoindole derivatives |
| 08/02/1992 | WO1992013538A1 Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis |
| 08/02/1992 | CA2101547A1 Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis |
| 08/02/1992 | CA2060352A1 Benzyloxyphenyl derivatives |
| 08/02/1992 | CA2060083A1 Phosphatidylinositol analogues, inhibitors of phosphatidylinositol-specific phospholipase c |
| 08/02/1992 | CA2059906A1 Heterocyclic amido prostaglandin analogs |
| 08/02/1992 | CA2059477A1 3-quinuclidine derivatives |
| 08/02/1992 | CA2058797A1 Amino acid derivatives |
| 08/01/1992 | WO1992013843A1 Synthesis of intermediates in the preparation of acat inhibitors |
| 08/01/1992 | CA2099564A1 Synthesis of intermediates in the preparation of acat inhibitors |
| 08/01/1992 | CA2060387A1 Tetrazole derivatives, process for their preparation and their use |
| 08/01/1992 | CA2060277A1 Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent |
| 08/01/1992 | CA2060064A1 Azapirones: use in attention deficit hyperactivity disorder |
| 07/31/1992 | WO1992013895A1 LOW-MOLECULAR SULPHATED POLY-β-2,6-FRUCTOFURANOSANES AND THEIR USE IN THE TREATMENT OF DEGENERATIVE ARTICULAR AILMENTS |
| 07/31/1992 | WO1992013839A1 Dihydropyridine compounds, and process for their preparation |
| 07/31/1992 | CA2101630A1 Niedermolekulare sulfatierte poly-.beta.-2,6-fructofuranosane und deren verwendung zur behandlung von degenerativen gelenkserkrankungen ( low molecular sulphated poly-.beta.-2,6 fructofuranosanes and their use in the treatment of degenerati e articular ailments) |
| 07/31/1992 | CA2078338A1 Dihydropyridine compounds, and process for their preparation |
| 07/31/1992 | CA2060154A1 Angiotensin ii receptor blocking quinazolones |
| 07/31/1992 | CA2060068A1 Pharmaceutical chewing gum containing acetylsalicylic acid |
| 07/31/1992 | CA2060055A1 Substituted pyrrolo-fused 6-membered heterocycles as angiotensin ii antagonists |
| 07/31/1992 | CA2035311A1 Use of an imidazopyridine for the manufacture of anaesthetic medications |
| 07/30/1992 | WO1992012969A1 Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion |
| 07/30/1992 | WO1992012709A1 Aryl macrocyclic compositions for treating viral infections |
| 07/30/1992 | WO1992012708A1 Anti-coagulant properties of macrocyclic compounds and method of treatment |
| 07/30/1992 | WO1992012636A1 Derivatives of porphycene of direct utility in photodynamic therapy or as intermediates for synthesis of photoactivatable dyes suitable for photodynamic therapy |
| 07/30/1992 | DE4200555A1 Antimicrobial camomile extracts used for e.g. vaginal douche |
| 07/30/1992 | DE4102244A1 14,16ss-ethano-15ss, 16(pfeil hoch)1(pfeil hoch)-cyclo-14ss-estra-1,3,5(10)-triene 14,16ss-ethano-15SS, 16 (arrow up) 1 (arrow up) cyclo-14ss-estra-1,3,5 (10) -trienes |
| 07/30/1992 | DE4101910A1 Verfahren zur herstellung eines pyrogenfreien gut wasserloeslichen fructans sowie ein nierendiagnostikum, das ein solches fructan enthaelt Process for the preparation of a pyrogen well wasserloeslichen fructans and a renal diagnostic that such a fructan contains |
| 07/30/1992 | DE4101873A1 Peroral applizierbare arzneiform zur behandlung zentraler dopaminmangelzustaende Orally administered drug form for treatment central dopaminmangelzustaende |
| 07/30/1992 | DE3943551A1 Compsns. for treating mycobacterial infection - comprises rifampicin, sulphamethoxazole, trimethoprim and prothionamide |
| 07/30/1992 | CA2101780A1 Derivatives of porphycene of direct utility in photodynamic therapy or as intermediates for synthesis of photoactivatable dyes suitable for photodynamic therapy |
| 07/30/1992 | CA2100676A1 Anti-coagulant properties of macrocyclic compounds and method of treatment |
| 07/30/1992 | CA2100574A1 Aryl macrocyclic compositions for treating viral infections |
| 07/30/1992 | CA2099117A1 Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion |
| 07/30/1992 | CA2060138A1 New use of the adenosine antagonist |
| 07/30/1992 | CA2035143A1 Compositions with enhanced penetration |
| 07/29/1992 | EP0496692A1 2-Methoxyphenylpiperazine derivatives |
| 07/29/1992 | EP0496691A1 Diphenylmethylpiperazine derivatives |
| 07/29/1992 | EP0496641A2 Cobalt complexes as anticancer agents |
| 07/29/1992 | EP0496617A1 Adenosine kinase inhibitors |
| 07/29/1992 | EP0496561A2 [[(2-Amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives |
| 07/29/1992 | EP0496548A1 Carbacyclin analogs |
| 07/29/1992 | EP0496520A1 Novel bone acting agents |
| 07/29/1992 | EP0496479A1 NADH and NADPH as energy-substitutes |
| 07/29/1992 | EP0496437A2 Use of specific core material and layers to obtain pharmaceutical formulations stable to discolouration of omeprazole |